Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announces that it has entered into a Restructuring Support Agreement (“RSA”) with its Prepetition First Lien Lenders and Ad Hoc Group of Noteholders, constituting substantially all of its junior creditors, to implement a comprehensive recapitalization transaction that will strengthen its capital structure. To implement the transaction, Inotiv has filed a voluntary, prepackaged chapter 11 case in the U.S. Bankruptcy Court for the Southern District of Texas.
Read the full article: Inotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future Growth //
Source: https://www.businesswire.com/news/home/20260602272707/en/Inotiv-Reaches-Agreement-to-Strengthen-Capital-Structure-and-Position-Company-for-Future-Growth